Chromium picolinate induced apoptosis of lymphocytes and the signaling mechanisms thereof

Toxicology and Applied Pharmacology

Volumn 237, Issue 3, 2009, Pages 331-344

  Jana, Mahadevan ^a   Rajaram, Anantanarayanan ^a   Rajaram, Rama ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Antioxidant; Apoptosis; Caspase 3; Chromium (III) picolinate; Electron microscopy; Mitochondrial membrane potential; ROS

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; CHROMIUM PICOLINATE; CYTOCHROME C; LIPOCORTIN 5; PICOLINIC ACID; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL ULTRASTRUCTURE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DNA FRAGMENTATION; DRUG ANTAGONISM; DRUG UPTAKE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOCYTE STRUCTURE; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; HUMANS; LYMPHOCYTES; PICOLINIC ACIDS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 65749093459     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.04.006     Document Type: Article

References (70)

1. Anderson R.A. Nutritional role of chromium in glucose and lipid metabolism in humans. Metal Ions in Biology and Medicine (1990) 95-99
2. Anderson R.A. Chromium, glucose intolerance and diabetes. J. Am. Coll. Nutr. 17 (1998) 548-555
3. Anderson R.A., Bryden N.A., and Polansky M.M. Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 16 (1997) 273-279
4. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., and Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46 (1997) 1786-1789
5. Anderson R.A., Polansky M.M., and Bryden N. Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Biol. Trace Elem. Res. 101 (2004) 211-218
6. Andersson M.A., Peterson K.V., Karlsson O.M., Lilianne A.G., Zetterberg A., and Hellman B.E. Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells and in vitro. Food Chem. Toxicol. 45 (2007) 1097-1106
7. Balamurugan K., Rajaram R., Ramasami T., and Narayanan S. Chromium(III) induced apoptosis of lymphocytes: death decision by ROS and Src-family tyrosine kinases. Free Radic. Biol. Med. 33 (2002) 1622-1640
8. Baskic D., Popovic S., Ristic P., and Arsenijevic N.N. Analysis of cycloheximide induced apoptosis in human leukocytes. Fluorescence microscopy using annexin V/propidium iodide versus acridine orange/ethidium bromide. Cell Biol. Int. 30 (2006) 924-932
9. Boyum A. Isolation of leukocytes from blood and bone marrow. J. Clin. Lab. Invest. 21 (1996) 77-79
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
11. Campling D.G., Pym J., Baker HM., Cole SP., and Lam Y.M. Chemosensitivity testing of small cell lung cancer using the MTT assay. Br. J. Cancer 63 (1991) 75-83
12. Chaudhary S., Pinkston J., Rabile M.M., and Horn J.D.V. Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes. J. Inorg. Biochem. 99 (2005) 787-794
13. Code of Federal Regulation. Title 21, Part 101.9 (c) (8) (iv) (2004), US Government Printing Office, Washington, DC
14. Connett P.H., and Wetterhahn K.E. Metabolism of the carcinogen chromate by cellular constituents. Struct. Bond. 54 (1983) 93-124
15. Cotton F.A., and Willinson G. The Chemistry of transition elements. Chromium. Group VI B (6). Advanced Inorganic Chemistry. 5th ed. (1988), John Wiley & Sons, NY, USA 679-697
16. Council for Responsible Nutrition, 2004. Chromium picolinate: safe at a wide range of intakes.
17. Davis C.M., and Vincent J.B. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36 (1997) 4382-4385
18. Ding W., Chai Z., Duan P., Feng W., and Qian Q. Serum and urine chromium concentrations in elderly diabetes. Biol. Trace Elem. Res. 63 (1998) 231-237
19. Eastmond D.A., MacGregor J.T., and Sleninski R.S. Trivalent chromium: assessing the genotoxic risk of an essential trace element and widely used human and animal nutritional supplement. Crit. Rev. Toxicol. 38 (2008) 173-190
20. Evans G.W., and Pouchmik D.J. Composition and biological activity of chromium-pyridine carboxylate complexes. J. Inorg. Biochem. 49 (1993) 177-187
21. Food and Nutrition Board, Institute of Medicine. Chromium. Dietary Reference Intakes for Vitamin A, Vitamin C, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc (2002), National Academy Press, Washington, DC 197-223
22. Grevatt P.C. Toxicological Review of Hexavalent Chromium (1988), U.S. Environmental production agency, Washington DC USA
23. Hepburn D.D.D., and Vincent J.B. Tissue and subcellular distribution of chromium picolinate with time after entering the blood stream. J. Inorg. Biochem. 94 (2003) 86-93
24. Hepburn D.D., Xiao J., Bindom S., Vincent J.B., and O'Donnell J. Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster. Proc. Natl. Acad. Sci. 100 (2003) 3766-3771
25. Hepburn D., Burney M., Wosky S., and Vincent J.B. The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vivo. Polyhedron 22 (2003) 455-463
26. Herrmann M., Lorenz H.M., Voll R., Grunke M., Woith W., and Kalden J.R. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22 (1994) 5506-5507
27. Hininger I., Benaraba R., Osman M., Faure H., Roussel A.M., and Anderson R.A. Safety of trivalent chromium complexes: no evidence for DNA damage in human HaCaT keratinocytes. Free Radic. Biol. Med. 42 (2007) 1759-1765
28. IARC. Monograph on the evaluation of carcinogenic risk to human. Chromium, nickel and welding. (IARC Lyon, France) 48 (1990) 49-508
29. Imamoglu N., Uyamk F., Kocaglu G.B., Erdem O., Cem L.B., and Donmez A.H. Effect of chromium picolinate on micronucleus frequency and morphology of lymphocytes in calves. Biol. Trace Elem. Res. 125 (2008) 133-140
30. Institute of Medicine. Dietary References Intakes for Vitamin A, Vitamin K, Arsenic Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc (2001), National Academy Press, Washington, DC
31. Jeejeebhoy K.N., Chu R.C., and Marliss E.B. Chromium deficiency, glucose intolerance and neuropathy reversed by chromium supplementation in a patient receiving long term parental nutrition. Am. J. Clin. Nutr. 30 (1977) 531-538
32. Kareus A., Kelley C., Walton H.S., and Sinclair P.R. Release of Cr(III) from Cr(III) picolinate upon metabolic activation. J. Hazard. Mater. B24 (2001) 163-174
33. Kato I., Vogelman J.H., Dilman V., Karkoszka J., Frenkel K., Durr N.P., Orentreich N., and Toniolo P. Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil. Eur. J. Epidemiol. 14 (1998) 621-626
34. Kuwana T., and Newmeyerm D.D. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr. Opin. Cell Biol. 15 (2003) 691-699
35. Lavina A., and Lay P.A. Chemical properties and toxicity of chromium (III) nutritional supplements. Chem. Res. Toxicol. 21 (2008) 563-571
36. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′7′Dichlorofluorescein as an indicator of ROS formation and oxidative stress. Chem. Res. Toxicol. 5 (1992) 227-231
37. Lee L.F. In vitro assay of mitogen stimulation of avian peripheral lymphocytes. Avian Dis. 18 (1974) 602-609
38. Lee J.H., Jung J.Y., Jeong Y.J., Park J.H., Yang K.H., Choi N.K., Kim S.H., and Kim W.J. Involvement of both mitochondria- and death receptor-dependent apoptotic pathways regulated by Bcl-2 family in sodium fluoride-induced apoptosis of the human gingival fibroblasts. Toxicology 243 (2008) 340-347
39. Manygoats K.R., Yazzie M., and Strearns D.M. Ultrastructural damage in chromium picolinate-treated cells: a TEM study. J. Biol. Inorg. Chem. 7 (2002) 791-798
40. Mao Y., Song G., Cai Q., Liu M., Luo H., Shi M., Ouyang G., and Bao S. Hydrogen peroxide-induced apoptosis in human gastric carcinoma MGC803 cells. Cell Biol. Int. 30 (2006) 332-337
41. Marchetti P., Castedo M., Susin S.A., Zamzami N., Hirsch T., Haeffner, Hirsch F., Geuskens M., and Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184 (1996) 1155-1160
42. Martínez M.C., and Freyssinet J.M. Deciphering the plasma membrane hallmarks of apoptotic cells: phosphatidylserine transverse redistribution and calcium entry. BMC Cell Biol. 2 (2001) 20
43. Mertz W. Effects and metabolism of glucose tolerance factor. Arch. Biochem. Biophys. 85 (1959) 292-295
44. Mertz W. Chromium in human nutrition: a review. J. Nutr. 123 (1993) 626-633
45. Mulyani I., Levina A., and Lay P.A. Biomimetic oxidation of chromium (III): does the antidiabetic activity of chromium (III) involve carcinogenic chromium (VI)?. Angew. Chem., Int. 43 (2004) 4504-4507
46. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., and Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. 95 (1998) 14681-14686
47. Nguyen A., Mulyani I., Levina A., and Lay P.A. Reactivity of chromium(III) nutritional supplements in biological media: an X-ray absorption spectroscopic study. Inorg. Chem. 47 (2008) 4299-4309
48. Ogata S., Inoue K., Iwata K., Okumura K., and Taguchi H. Apoptosis induced by picolinic acid related compounds in HL-60 cells. Biosci. Biotechnol. Biochem. 65 (2001) 2337-2339
49. Penninger J.M., and Kroemer G. Mitochondria, AIF and caspases-rivaling for cell death execution. Nat. Cell Biol. 5 (2003) 97-99
50. Rajaram R., Nair B.U., and Ramasami T. Chromium(III) induced abnormalities in human lymphocytes cell proliferation: evidence for apoptosis. Biochem. Biophys. Res. Commun. 210 (1995) 434-440
51. Rhodes M.C., He'bert C.D., Herbert R.A., Morinello E.J., Roycroft J.H., Travlos G.S., and Abdo K.M. Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food Chem. Toxicol. 43 (2005) 21-29
52. 6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 441 (1997) 77-82
53. Speetjens J.K., Collins R.A., Vincent J.B., and Woski S.A. The Nutritional supplement Chromium (III)tris picolinate cleaves DNA. Chem. Res. Toxicol. 12 (1999) 483-487
54. Spector D.L., Goldma R.D., and Leinwand L.A. Cells: A Laboratory Manual. Vol 1; Culture and Biochemical Analysis of Cells (1988), Cold Spring Harbor Laboratory Press, New York
55. Stallings D.M., Hepburn D.D.D., Hannah M., Vincent J.B., and O'Donnell J. Nutritional supplement chromium picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster. Mutat. Res. 610 (2006) 101-113
56. Stearns D.M. In: Vincent J.B. (Ed). The Nutritional Biochemistry of Chromium (III) (2007), Elsevier, Amsterdam 209-225
57. Stearns D.M., Belbruno J.J., and Wetterhahn K.E. A prediction of Cr(III) accumulation in humans from chromium dietary supplements. FASEB J. 9 (1995) 1650-1657
58. Stearns D.M., Wise J.P., Patierno S.R., and Wetterhahn K.E. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 9 (1995) 1643-1648
59. Sugden K.D., Geer R.D., and Rogers S.J. Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. Biochemistry 31 (1992) 11626-11631
60. Talwar G.P. A Handbook of Practical Immunology (1983), Vikas Publishing House Private Limited, New Delhi. India 328-336
61. Testa U., Louache F., Titeux M., Thomopoulos P., and Rochant H. The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines. Br. J. Haematol. 60 (1985) 491-502
62. Vasant C., Balamurugan K., Rajaram R., and Ramasami T. Apoptosis of lymphocytes in the presence of Cr(V) complexes: role in Cr(VI) induced toxicity. Biochem. Biophys. Res. Commun. 284 (2001) 1354-1360
63. Vincent J.B. The biochemistry of chromium. J. Nutr. 88 (2000) 439-445
64. Vincent J.B. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med. 33 (2003) 213-230
65. Whittaker P., San R.H.C., Clarke J.J., Seifried H.E., and Dunkel V.C. Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food Chem. Toxicol. 43 (2005) 1619-1625
66. Witmer C., Faraia E., Park H.S., Sadrieh N., Yurkow E., O'Connell S., Sirak A., and Schleyer H. In Vivo effects of chromium. Environ. Health Perspect. 102 (1994) 167-176
67. Wu Y.J., Muldoon L.L., and Neuwelt E.A. The chemoprotective agent for N-acetyl cysteine blocks cisplatin induced apoptosis through caspases signaling pathway. J. Pharmacol. Exp. Ther. 312 (2005) 424-431
68. Yang J.C., and Cortopassi G.A. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic. Biol. Med. 24 (1998) 624-631
69. 3 improves insulin responsiveness and reduces whole body glucose tolerance. FEBS Lett. 579 (2005) 1458-1464
70. Yamamoto A., Wada O., and Ondo T. Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver. Eur. J. Biochem. 165 (1987) 67-631